NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Alto Neuroscience, Inc. ("Alto" or the "Company") (NYSE: ANRO) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? If you purchased or acquired Alto securities, and/or would like to discuss your legal rights and options please visit Alto Neuroscience, Inc. Shareholder Class Action ...

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Lockheed Martin Corporation (“Lockheed Martin” or the “Company”) (NYSE: LMT) between January 23, 2024 and July 21, 2025, inclusive. For more information, submit a form at Lockheed Martin Corporation Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at pallocco ...

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired publicly traded Sable Offshore Corp. (“Sable Offshore” or the “Company”) (NYSE: SOC) securities between May 19, 2025 and June 3, 2025, inclusive (the “Class Period”), and/or pursuant and/or traceable to the Company’s May 21, 2025 secondary public offering. For more information, submit a form at Sable Offshor ...

Core Viewpoint - A shareholder has filed a securities class action lawsuit against Flywire Corporation, alleging misrepresentations regarding the company's revenue growth between February 28, 2024, and February 25, 2025 [1][2]. Summary by Sections Lawsuit Details - The lawsuit is on behalf of investors who purchased or acquired Flywire's securities during the specified period [1]. - Defendants are accused of making false statements about the strength and sustainability of Flywire's revenue growth [2]. Lead Plaintiff Information - Interested parties must file papers by September 23, 2025, to serve as lead plaintiff, representing the class in the litigation [3]. - Participation as a lead plaintiff is not required to share in any potential recovery, and shareholders incur no fees or expenses [3]. Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented large public and private pension funds [4]. - The firm has been recognized multiple times for its success in litigating class actions [4].

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the "Class") who purchased or acquired: (a) Alto Neuroscience, Inc. ("Alto" or the "Company") (NYSE: ANRO) common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company's initial public offering conducted on or about February 2, 2024 (the "IPO" or "Offering"); and/or (b) Alto securities between February 2, ...

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the "Class") who purchased or acquired the securities of Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS) between April 29, 2025 and June 22, 2025, inclusive. Should You Join This Class Action Lawsuit? If you purchased or acquired Hims securities, and/or would like to discuss your legal rights and options please visit Hims & Hers H ...

Core Viewpoint - A shareholder has filed a securities class action lawsuit against Sarepta Therapeutics, Inc. for alleged misrepresentations regarding the safety risks of its product ELEVIDYS, which is intended to treat Duchenne muscular dystrophy [1][2]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased or acquired Sarepta securities between June 22, 2023, and June 24, 2025 [1]. - Defendants are accused of making false statements about the safety risks associated with ELEVIDYS [2]. Group 2: Legal Participation - Investors wishing to serve as lead plaintiff must file papers by August 25, 2025, but participation as a class member does not require serving as lead plaintiff [3]. - All legal representation is on a contingency fee basis, meaning shareholders incur no fees or expenses [3]. Group 3: Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has represented both individual investors and large pension funds [4]. - The firm has been recognized multiple times for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times [4].

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the "Class") who purchased or acquired the securities of Centene Corporation ("Centene" or the "Company") (NYSE: CNC) between December 12, 2024 and June 30, 2025, inclusive. Should You Join This Class Action Lawsuit? If you purchased or acquired Centene securities, and/or would like to discuss your legal rights and options please visit Centene Co ...

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the "Class") who purchased or acquired the securities of Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) between October 9, 2024 and July 10, 2025, inclusive. ATTORNEY ADVERTISING. © 2025 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New Y ...

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years. A ...